Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at NOK 221.8B, ahead of Biogen (NOK 178.3B) and Amgen (NOK 84.6B). Figures as of 20 Nov 2026, 07:57 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesNOK 221.8B
Median
NOK 15.7B
Combined market value
NOK 7.18T
Countries
1

Market values as of .

United States
All sectors
Biotech
NOK
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareNOK 221.8BNOK 2.02TNOK 1,626.61 1.45% down 35% up United States
2BiogenBIIB · Health CareNOK 178.3BNOK 356.8BNOK 2,413.88 1.70% down 49% up United States
3AmgenAMGN · Health CareNOK 84.6BNOK 2.32TNOK 4,286.25 1.14% down 32% up United States
4ModernaMRNA · Health CareNOK 84.5BNOK 787.8BNOK 1,946.99 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareNOK 31.8BNOK 154.8BNOK 1,529.52 3.85% down 17% up United States
6VaxcytePCVX · Health CareNOK 26.2BNOK 90.2BNOK 570.04 0.27% down 23% up United States
7ExelixisEXEL · Health CareNOK 21.1BNOK 156.9BNOK 643.01 3.60% down 63% up United States
8Bio-TechneTECH · Health CareNOK 20.6BNOK 111.6BNOK 710.11 0.07% down 24% up United States
9RepligenRGEN · Health CareNOK 20.6BNOK 106.3BNOK 1,663.34 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareNOK 15.9BNOK 336.8BNOK 1,557.26 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareNOK 15.4BNOK 99.6BNOK 1,166.16 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareNOK 11.9BNOK 91.4BNOK 3,084.83 0.15% up 54% up United States
13ImmunovantIMVT · Health CareNOK 8.3BNOK 65.7BNOK 317.64 1.96% down 46% up United States
14CG OncologyCGON · Health CareNOK 7.4BNOK 71.5BNOK 799.97 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareNOK 4.6BNOK 74.3BNOK 1,090.27 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareNOK 2.4BNOK 60BNOK 492.00 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareNOK 2.1BNOK 44.4BNOK 273.98 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareNOK 1.5BNOK 62.5BNOK 956.25 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareNOK 476.8MNOK 103.6BNOK 908.78 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-NOK 4.9BNOK 68.3BNOK 64.17 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7677 NOK).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (NOK 221.8B), Biogen (NOK 178.3B) and Amgen (NOK 84.6B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 07:57 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of NOK 7.18T as of 20 Nov 2026, 07:57 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.